Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Nakao

Showing results (31-40 of 69) with videos related to

Pageof 7
Sort By:
Internal Medicine (Tokyo, Japan)|August 11, 2017
Successful Treatment with Alectinib for Choroidal Metastasis in Anaplastic Lymphoma Kinase Rearranged Non-small Cell Lung CancerTomoko Funazo, Kyohei Morita, Naoya Ikegami, et al.
Cureus|October 3, 2025
Evaluation of Intraocular Anti-vascular Endothelial Growth Factor (VEGF) Drug-Associated Adverse Events Using Spontaneous Reporting DatabasesMugita Sato, Koichi Kageyama, Seiichiro Ito, et al.
Journal of the Neurological Sciences|November 20, 2023
Progressive multifocal leukoencephalopathy analyzed using the Japanese Adverse Drug Event Report databaseShuji Sakurai, Mika Maezawa, Satoshi Nakao, et al.
Pharmacoepidemiology and Drug Safety|September 2, 2020
Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report databaseShiori Hasegawa, Hiroaki Ikesue, Satoshi Nakao, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 3, 2017
Adverse Event Trends Associated with OTC Analgesic and Antipyretic Drug: Data Mining of the Japanese Adverse Drug Event Report DatabaseShiori Hasegawa, Haruna Hatahira, Misa Naganuma, et al.
Helicobacter|December 23, 2017
Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trialSoichiro Sue, Marina Ogushi, Isao Arima, et al.
Biological & Pharmaceutical Bulletin|December 3, 2020
Trends Associated with Hemorrhoids in Japan: Data Mining of Medical Information Datasets and the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data JapanRirika Mukai, Kazuyo Shimada, Takaaki Suzuki, et al.
BMC Pharmacology & Toxicology|August 31, 2021
Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report databaseSatoshi Nakao, Shiori Hasegawa, Ryogo Umetsu, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|December 1, 2021
Development of Liquid-Chromatography Tandem-Mass-Spectrometry Method for Determining Environmental Contamination by Powdered Medicinal Drugs in PharmaciesShiori Hasegawa, Ryoichi Inaba, Hiroki Nakamura, et al.
Plos One|September 28, 2017
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting systemAkiho Fukuda, Kohei Tahara, Yuuki Hane, et al.
Pageof 7

Showing results (31-40 of 69) with videos related to

Sort By:
Pageof 7
Internal Medicine (Tokyo, Japan)|August 11, 2017
Successful Treatment with Alectinib for Choroidal Metastasis in Anaplastic Lymphoma Kinase Rearranged Non-small Cell Lung CancerTomoko Funazo, Kyohei Morita, Naoya Ikegami, et al.
Cureus|October 3, 2025
Evaluation of Intraocular Anti-vascular Endothelial Growth Factor (VEGF) Drug-Associated Adverse Events Using Spontaneous Reporting DatabasesMugita Sato, Koichi Kageyama, Seiichiro Ito, et al.
Journal of the Neurological Sciences|November 20, 2023
Progressive multifocal leukoencephalopathy analyzed using the Japanese Adverse Drug Event Report databaseShuji Sakurai, Mika Maezawa, Satoshi Nakao, et al.
Pharmacoepidemiology and Drug Safety|September 2, 2020
Analysis of immune-related adverse events caused by immune checkpoint inhibitors using the Japanese Adverse Drug Event Report databaseShiori Hasegawa, Hiroaki Ikesue, Satoshi Nakao, et al.
Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|October 3, 2017
Adverse Event Trends Associated with OTC Analgesic and Antipyretic Drug: Data Mining of the Japanese Adverse Drug Event Report DatabaseShiori Hasegawa, Haruna Hatahira, Misa Naganuma, et al.
Helicobacter|December 23, 2017
Vonoprazan- vs proton-pump inhibitor-based first-line 7-day triple therapy for clarithromycin-susceptible Helicobacter pylori: A multicenter, prospective, randomized trialSoichiro Sue, Marina Ogushi, Isao Arima, et al.
Biological & Pharmaceutical Bulletin|December 3, 2020
Trends Associated with Hemorrhoids in Japan: Data Mining of Medical Information Datasets and the National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB) Open Data JapanRirika Mukai, Kazuyo Shimada, Takaaki Suzuki, et al.
BMC Pharmacology & Toxicology|August 31, 2021
Pharmacovigilance study of anti-infective-related acute kidney injury using the Japanese adverse drug event report databaseSatoshi Nakao, Shiori Hasegawa, Ryogo Umetsu, et al.
Inquiry : a Journal of Medical Care Organization, Provision and Financing|December 1, 2021
Development of Liquid-Chromatography Tandem-Mass-Spectrometry Method for Determining Environmental Contamination by Powdered Medicinal Drugs in PharmaciesShiori Hasegawa, Ryoichi Inaba, Hiroki Nakamura, et al.
Plos One|September 28, 2017
Comparison of the adverse event profiles of conventional and liposomal formulations of doxorubicin using the FDA adverse event reporting systemAkiho Fukuda, Kohei Tahara, Yuuki Hane, et al.
Pageof 7